Key result
Longer total stent length quartiles evaluated for MI and stent thrombosis risk in ACS.
Why the study?
Little is known about the impact of stent length on readmission for MI and ST after discharge for ACS treated with PCI and second generation DES.
Does longer total stent length increase the risk of readmission for myocardial infarction or stent thrombosis in acute coronary syndrome patients undergoing PCI with second-generation drug-eluting stents?
Cohort (n=3,263)
No
Does longer total stent length increase the risk of readmission for myocardial infarction or stent thrombosis in acute coronary syndrome patients undergoing PCI with second-generation drug-eluting stents?
This retrospective cohort study investigates the relationship between total second-generation DES length and subsequent myocardial infarction or stent thrombosis in 3,263 ACS patients, although the results section is missing from the provided text.
Answers are grounded in this paper and cite their sources.
Longer stent length's association with MI or thrombosis in ACS remains inconclusive; leaves open independent risk prediction after second-generation DES.
Background: Little is known about the impact of stent length on readmission for myocardial infarction (MI) and stent thrombosis (ST) after discharge for an acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI) and second generation drug-eluting stents (DES). We investigated the relationship between stent length and MI/ST in a contemporary cohort of ACS patients treated with second generation DES. Methods: Retrospectively, between 2010 and 2017, 3263 consecutive ACS patients in a tertiary cardiology department underwent PCI with DES implantation during the index coronary event, and received dual antiplatelet therapy at discharge. Patients with triple therapy were excluded for the purpose of this study. We examined second generation DES treated patients in stent length quartiles: Q1 (7–18mm), Q2 (19–32mm), Q3 (33–53mm), Q4 (>53mm). MI/ST during follow-up in each quartile was determined and compared being Q1 the reference group. Adjusted hazard ratios (HR) and 95% confidence intervals were generated using multivariable Cox regression model.
No takes yet. Share an insight, caveat, or question.
Queija et al. (2018) conducted a cohort in Acute coronary syndrome undergoing PCI with second-generation drug-eluting stents (n=3,263). Longer total stent length (Q2: 19-32mm, Q3: 33-53mm, Q4: >53mm) with second-generation DES vs. Shortest stent length quartile Q1 (7-18mm) was evaluated on Readmission for myocardial infarction (MI) or stent thrombosis (ST) during follow-up. Total stent length quartiles (Q2 19-32mm, Q3 33-53mm, Q4 >53mm vs Q1 7-18mm) were evaluated for MI or stent thrombosis in 3,263 ACS patients, though outcome rates are truncated in the text.
Synapse has enriched 10 related papers. Consider them for comparative context: